Singapore’s Health Sciences Authority (HSA) has cleared unaffected batches of Medicube PDRN Pink Collagen Capsule Cream for resale after a recent scare involving the industrial dye Sudan IV. Testing revealed minute traces of the banned substance in two samples of the cream sold by Venus Beauty. The HSA determined that only specific batches were affected and posed a potential health risk due to Sudan IV being a prohibited cancer-causing agent. Consumers had previously been advised to stop using the cream, prompting a recall of affected products. With the clearance of unaffected batches, the product can now return to shelves, but consumers are still urged to verify batch numbers. The HSA continues to monitor the situation and emphasizes the importance of cosmetic product safety standards.